2Gumm stepnens JC, Thompson JR, Bathbome B J, et al. Significant association of caga positive Helicobacter pylori strains with ris B of prematr myocardial infarction[J]. Heart, 2000, 84 (3): 267-271.
4Graham DY.Antibiotic resistance in Helicobacter pylori:implications for therapy. Gastroenterology,1995,115:1272
5Cammarota G,Cianci R,Cannizzaro O,et al.Efficacy of two one - week rabeprazole/levofloxacin - based triple therapies for Helicobacter pylori infectien. Aliment Pharmacol Ther,2000,14(10):1339
6Di Caro S,Assunta Zocco M,Cremonini F,et al.Levofloxacin based regimens for the eradication of Helicobacter pylori.Eur J Gastroenterol Hepatol ,2002,14(12) :1309
7Choi BY,Park HJ,Hwang SJ,et al.Preparation of alginate beads forfloating drug delivery system effect of CO2 gas-forming agents[J].Int JPharm,2002,239(1/2):81-91.
8Sato Y,Kawashima Y,Takeuchi H,et al.In vivo evaluation of ri-boflavin-containing microballoons for floating controlled drug deliverysystem in healthy humans[J].Int J Pharm,2004,275(1/2):97-107.
9Sato Y,Kawashima Y,Takeuchi H,et al.In vivo evaluation of ri-boflavin-containing microballoons for floating controlled drug deliverysystem in healthy human volunteers[J].J Controll Release,2003,93(1):39-47.
10Atyabi F,Sharma HL,Mohammad HAH,et al.In vivo evaluation of anovel gastric retentive formulation based on ion exchange resins[J].J Con-trll Release,1996,42(2):105-113.
